These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24974974)

  • 1. Computational methods to identify new antibacterial targets.
    McPhillie MJ; Cain RM; Narramore S; Fishwick CW; Simmons KJ
    Chem Biol Drug Des; 2015 Jan; 85(1):22-9. PubMed ID: 24974974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico analyses for the discovery of tuberculosis drug targets.
    Chung BK; Dick T; Lee DY
    J Antimicrob Chemother; 2013 Dec; 68(12):2701-9. PubMed ID: 23838951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targets for antibiotic drug design.
    Ali ST; Gill AE; Lewendon A
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1712-7. PubMed ID: 12528303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New screens and targets in antibacterial drug discovery.
    Falconer SB; Brown ED
    Curr Opin Microbiol; 2009 Oct; 12(5):497-504. PubMed ID: 19651534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenomic approaches to infer drug-target interaction networks.
    Yamanishi Y
    Methods Mol Biol; 2013; 939():97-113. PubMed ID: 23192544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging structural information for the discovery of new drugs: computational methods.
    Nguyen TB; Wong SE; Lightstone FC
    Methods Mol Biol; 2012; 841():209-34. PubMed ID: 22222454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    J Appl Microbiol; 2002; 92 Suppl():4S-15S. PubMed ID: 12000608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
    Sanyal G; Doig P
    Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-division inhibitors: new insights for future antibiotics.
    Lock RL; Harry EJ
    Nat Rev Drug Discov; 2008 Apr; 7(4):324-38. PubMed ID: 18323848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small and lethal: searching for new antibacterial compounds with novel modes of action.
    Pathania R; Brown ED
    Biochem Cell Biol; 2008 Apr; 86(2):111-5. PubMed ID: 18443624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of biophysical tools to target-based discovery of novel antibacterial leads.
    Lahiri S; Kazmirski S; Kern G; Sanyal G
    Curr Drug Targets; 2012 Mar; 13(3):388-408. PubMed ID: 22206259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive systems biology approach to broad-spectrum, host-directed drug target discovery in infectious diseases.
    Felciano RM; Bavari S; Richards DR; Billaud JN; Warren T; Panchal R; Krämer A
    Pac Symp Biocomput; 2013; ():17-28. PubMed ID: 23424108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase.
    Axerio-Cilies P; See RH; Zoraghi R; Worral L; Lian T; Stoynov N; Jiang J; Kaur S; Jackson L; Gong H; Swayze R; Amandoron E; Kumar NS; Moreau A; Hsing M; Strynadka NC; McMaster WR; Finlay BB; Foster LJ; Young RN; Reiner NE; Cherkasov A
    ACS Chem Biol; 2012 Feb; 7(2):350-9. PubMed ID: 22066782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to discovery of antibacterial agents.
    Taylor PL; Wright GD
    Anim Health Res Rev; 2008 Dec; 9(2):237-46. PubMed ID: 19006597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.